Will new studies cause large numbers of anti-vaxxers to say "Wow. It turns our vaccines don't cause autism after all. I've been wrong the whole time."?

Dr. Jay Bhattacharya, a Stanford professor against Covid lockdowns, is set for a Senate confirmation hearing to lead NIH. His nomination is contentious due to his unconventional background and Covid stance.

Trump’s pick for the NIH, Jay Bhattacharya, was right about COVID. And when the health care establishment went after him, he didn't buckle.

Jay Bhattacharya said he’s “convinced” by the data showing there is no link between the measles, mumps, and rubella vaccine and autism

Critics called Stanford’s Jay Bhattacharya a dangerous “fringe” thinker, because he stood up to the health care establishment’s authoritarian arrogance.

Jay Bhattacharya, President Donald Trump ’s nominee to direct the National Institutes of Health faced questions Wednesday during his Senate confirmation hearing about how he would lead the agency and whether he would support policies handed down from Trump and Health and Human Services Secretary Robert F. Kennedy Jr.

A federal judge blocked the Trump administration Wednesday from drastically cutting medical research funding that many scientists say will endanger patients and cost jobs.

Republicans, like Senate HELP Chair Bill Cassidy (R-La.), will give Bhattacharya a chance to articulate his plans for the agency. “Excellent conversation with Dr. Jay,” Cassidy posted on X on ...

President Donald Trump’s pick to lead the National Institutes of Health answered sharp questions in a confirmation hearing Wednesday about his views on vaccines, research funding and the role scientists should play in a pandemic.

A health economist who once famously clashed with officials at the National Institutes of Health and now is the nominee to lead the agency faced questions from senators from both parties Wednesday about drastic funding cuts and research priorities.

President Donald Trump’s nominee to lead the National Institutes of Health, Dr. Jay Bhattacharya, on Wednesday fielded a wide swath of questions from senators that largely revolved around how he plans to restore public trust in the nation’s premier biomedical research agency.